SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-026842
Filing Date
2019-05-01
Accepted
2019-05-01 17:55:18
Documents
2
Period of Report
2019-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6485
2 POA DOCUMENT poa.txt EX-24.4_849915 2078
  Complete submission text file 0001209191-19-026842.txt   9956
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 19788998